Literature DB >> 29770066

Latent tuberculosis infection: An overview.

S Kiazyk1,2, T B Ball1,2,3.   

Abstract

Latent tuberculosis infection (LTBI) is defined as a state of persistent immune response to stimulation by Mycobacterium tuberculosis antigens without evidence of clinically manifested active tuberculosis (TB) disease. Individuals with LTBI represent a reservoir for active TB cases. The detection and management of LTBI is now a key component of the World Health Organization's End TB Strategy and the Government of Canada's federal framework for action on TB prevention and control. This is because people with LTBI can progress to active TB or undergo reactivation, a risk that is greatly increased in those with immunocompromising conditions. This overview provides a summary of LTBI and reactivation risk, as well as the recent advances in the diagnosis and treatment of LTBI.

Entities:  

Year:  2017        PMID: 29770066      PMCID: PMC5764738          DOI: 10.14745/ccdr.v43i34a01

Source DB:  PubMed          Journal:  Can Commun Dis Rep        ISSN: 1188-4169


  35 in total

Review 1.  A consistent log-linear relationship between tuberculosis incidence and body mass index.

Authors:  Knut Lönnroth; Brian G Williams; Peter Cegielski; Christopher Dye
Journal:  Int J Epidemiol       Date:  2009-10-09       Impact factor: 7.196

Review 2.  Latent Mycobacterium tuberculosis infection.

Authors:  Haileyesus Getahun; Alberto Matteelli; Richard E Chaisson; Mario Raviglione
Journal:  N Engl J Med       Date:  2015-05-28       Impact factor: 91.245

Review 3.  The diagnostic accuracy of tests for latent tuberculosis infection in hemodialysis patients: a systematic review and meta-analysis.

Authors:  Thomas W Ferguson; Navdeep Tangri; Kerry Macdonald; Brett Hiebert; Claudio Rigatto; Manish M Sood; Souradet Shaw; Blake Lerner; Yang Xu; Salaheddin Mahmud; Paul Komenda
Journal:  Transplantation       Date:  2015-05       Impact factor: 4.939

4.  The prognosis of a positive tuberculin reaction in childhood and adolescence.

Authors:  G W Comstock; V T Livesay; S F Woolpert
Journal:  Am J Epidemiol       Date:  1974-02       Impact factor: 4.897

Review 5.  Tuberculosis diagnostics in 2015: landscape, priorities, needs, and prospects.

Authors:  Madhukar Pai; Marco Schito
Journal:  J Infect Dis       Date:  2015-04-01       Impact factor: 5.226

6.  Estimated rate of reactivation of latent tuberculosis infection in the United States, overall and by population subgroup.

Authors:  Kimberly M Shea; J Steve Kammerer; Carla A Winston; Thomas R Navin; C Robert Horsburgh
Journal:  Am J Epidemiol       Date:  2013-10-18       Impact factor: 4.897

7.  WHO's new end TB strategy.

Authors:  Mukund Uplekar; Diana Weil; Knut Lonnroth; Ernesto Jaramillo; Christian Lienhardt; Hannah Monica Dias; Dennis Falzon; Katherine Floyd; Giuliano Gargioni; Haileyesus Getahun; Christopher Gilpin; Philippe Glaziou; Malgorzata Grzemska; Fuad Mirzayev; Hiroki Nakatani; Mario Raviglione
Journal:  Lancet       Date:  2015-03-24       Impact factor: 79.321

Review 8.  Interferon-γ release assays for the diagnosis of tuberculosis and tuberculosis infection in HIV-infected adults: a systematic review and meta-analysis.

Authors:  Miguel Santin; Laura Muñoz; David Rigau
Journal:  PLoS One       Date:  2012-03-05       Impact factor: 3.240

Review 9.  Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries.

Authors:  Haileyesus Getahun; Alberto Matteelli; Ibrahim Abubakar; Mohamed Abdel Aziz; Annabel Baddeley; Draurio Barreira; Saskia Den Boon; Susana Marta Borroto Gutierrez; Judith Bruchfeld; Erlina Burhan; Solange Cavalcante; Rolando Cedillos; Richard Chaisson; Cynthia Bin-Eng Chee; Lucy Chesire; Elizabeth Corbett; Masoud Dara; Justin Denholm; Gerard de Vries; Dennis Falzon; Nathan Ford; Margaret Gale-Rowe; Chris Gilpin; Enrico Girardi; Un-Yeong Go; Darshini Govindasamy; Alison D Grant; Malgorzata Grzemska; Ross Harris; C Robert Horsburgh; Asker Ismayilov; Ernesto Jaramillo; Sandra Kik; Katharina Kranzer; Christian Lienhardt; Philip LoBue; Knut Lönnroth; Guy Marks; Dick Menzies; Giovanni Battista Migliori; Davide Mosca; Ya Diul Mukadi; Alwyn Mwinga; Lisa Nelson; Nobuyuki Nishikiori; Anouk Oordt-Speets; Molebogeng Xheedha Rangaka; Andreas Reis; Lisa Rotz; Andreas Sandgren; Monica Sañé Schepisi; Holger J Schünemann; Surender Kumar Sharma; Giovanni Sotgiu; Helen R Stagg; Timothy R Sterling; Tamara Tayeb; Mukund Uplekar; Marieke J van der Werf; Wim Vandevelde; Femke van Kessel; Anna van't Hoog; Jay K Varma; Natalia Vezhnina; Constantia Voniatis; Marije Vonk Noordegraaf-Schouten; Diana Weil; Karin Weyer; Robert John Wilkinson; Takashi Yoshiyama; Jean Pierre Zellweger; Mario Raviglione
Journal:  Eur Respir J       Date:  2015-09-24       Impact factor: 16.671

Review 10.  Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies.

Authors:  Christie Y Jeon; Megan B Murray
Journal:  PLoS Med       Date:  2008-07-15       Impact factor: 11.069

View more
  34 in total

1.  Tuberculosis among First Nations, Inuit and Métis children and youth in Canada: Beyond medical management.

Authors:  Radha Jetty
Journal:  Paediatr Child Health       Date:  2020-05-02       Impact factor: 2.253

Review 2.  Novel Approaches for the Treatment of Pulmonary Tuberculosis.

Authors:  Zhi Ming Tan; Gui Ping Lai; Manisha Pandey; Teerapol Srichana; Mallikarjuna Rao Pichika; Bapi Gorain; Subrat Kumar Bhattamishra; Hira Choudhury
Journal:  Pharmaceutics       Date:  2020-12-10       Impact factor: 6.321

3.  Design, synthesis and anti-mycobacterial evaluation of imidazo[1,2-a]pyridine analogues.

Authors:  Yogesh Mahadu Khetmalis; Surendar Chitti; Anjani Umarani Wunnava; Banoth Karan Kumar; Muthyala Murali Krishna Kumar; Sankaranarayanan Murugesan; Kondapalli Venkata Gowri Chandra Sekhar
Journal:  RSC Med Chem       Date:  2022-01-03

4.  Very-Rapidly Dissolving Printlets of Isoniazid Manufactured by SLS 3D Printing: In Vitro and In Vivo Characterization.

Authors:  Tahir Khuroo; Eman M Mohamed; Sathish Dharani; Canberk Kayalar; Tanil Ozkan; Mathew A Kuttolamadom; Ziyaur Rahman; Mansoor A Khan
Journal:  Mol Pharm       Date:  2022-06-01       Impact factor: 5.364

5.  Synthesis and evaluation of triazole congeners of nitro-benzothiazinones potentially active against drug resistant Mycobacterium tuberculosis demonstrating bactericidal efficacy.

Authors:  Santosh Kumar Sahoo; Mohammad Naiyaz Ahmad; Grace Kaul; Srinivas Nanduri; Arunava Dasgupta; Sidharth Chopra; Venkata Madhavi Yaddanapudi
Journal:  RSC Med Chem       Date:  2022-03-10

6.  Prevalence of Latent Tuberculosis in the Multiple Sclerosis Clinic and Effect of Multiple Sclerosis Treatment on Tuberculosis Testing.

Authors:  Andrew J Bouley; Ursela Baber; Emily Egnor; Soleil Samaan; Jacob A Sloane
Journal:  Int J MS Care       Date:  2020-04-14

7.  Non-healing Wounds: A Delayed Wound Infection by Mycobacterium Tuberculosis.

Authors:  Amrita Chaurasia; Vandana Ojha; Osheen Bonal; Yashi Srivastava
Journal:  J Obstet Gynaecol India       Date:  2020-05-06

8.  BCG vaccination reduces the mortality of Mycobacterium tuberculosis-infected type 2 diabetes mellitus mice.

Authors:  Rajesh Kumar Radhakrishnan; Ramya Sivangala Thandi; Deepak Tripathi; Padmaja Paidipally; Madeline Kay McAllister; Sachin Mulik; Buka Samten; Ramakrishna Vankayalapati
Journal:  JCI Insight       Date:  2020-03-12

Review 9.  Non-Coding RNAs in Tuberculosis Epidemiology: Platforms and Approaches for Investigating the Genome's Dark Matter.

Authors:  Ahmad Almatroudi
Journal:  Int J Mol Sci       Date:  2022-04-17       Impact factor: 6.208

10.  Evaluation of latent tuberculosis infection surveillance in Peel region, Ontario, 2010-2014.

Authors:  J A Majerovich; L Fernandes; M Varia
Journal:  Can Commun Dis Rep       Date:  2017-05-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.